Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    14500804 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
Condition: Osteoporosis
Interventions: Drug: PTH;   Drug: Alendronate
2 Active, not recruiting Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: denosumab;   Drug: teriparatide

Study has passed its completion date and status has not been verified in more than two years.